• Info
  • Insider Ownership

Insider Trading & Ownership of Kevin Damour

Location
Brooklyn, NY
Summary
The estimated net worth of Kevin Damour is at least $159,248 dollars as of 29 Jun 2022. Kevin Damour is the Chief Scientific Officer of Brooklyn ImmunoTherapeutics, Inc. and owns shares of Ernexa Therapeutics Inc. (ERNA) stock worth about $159.2K.
Signature
/s/ Kevin D'Amour
All Insider Reports
All Insider Reports

Notify me when Kevin Damour files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Kevin Damour

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ERNA, ERNAW Brooklyn ImmunoTherapeutics, Inc. Chief Scientific Officer $159,248 28 Jun 2022

Insider Transactions Reported by Kevin Damour:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.